Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지
DOI QR코드

DOI QR Code

The National Health Insurance Scheme for Herbal Medicines in Japan

일본 건강보험의 한약 급여제도 현황

  • Hyun, Eunhye (Department of Korean Medical Science, School of Korean Medicine, Pusan National University) ;
  • Lim, Byungmook (Division of Humanities and Social Medicine, School of Korean Medicine, Pusan National University)
  • 현은혜 (부산대학교 한의학전문대학원 한의과학과) ;
  • 임병묵 (부산대학교 한의학전문대학원 인문사회의학교실)
  • Received : 2022.04.07
  • Accepted : 2022.04.22
  • Published : 2022.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background & Objectives : As the government of South Korea implemented policies to strengthen health insurance coverage, the health insurance benefit for raw herbal medicines has been promoted. This study investigated the current status of the herbal medicines coverage in the Japanese national health insurance to secure reference data for the design of herbal medicines coverage in South Korea. Methods : Literature review was conducted to collect and analyze the history and current situation on herbal medicines coverage in the Japanese health insurance system. To supplement the contents not presented in the documents, on-site interviews were conducted at the medical institutions and pharmacies that prescribed or prepared herbal medicines in Tokyo, Japan. The contents of the survey included the background and progress of the herbal medicines coverage, the status of herbal medicines use, the payment system, and the safety management of herbal medicines. Results : Since the introduction of health insurance in the 1960s, Japanese insurance system has covered herbal medicines, and so far, it has been maintained without any additional restrictions. When the raw herbal medicines are prescribed to outpatients, the preparation fee is set higher than that of other medicines, but overall payment regulations and systems for herbal medicine are generally the same as other medicines. Conclusions : The case of Japan can be a useful references and implications for national health insurance policy on herbal medicines in south Korea.

Keywords

Acknowledgement

이 연구는 국민건강보험공단의 연구비 지원으로 수행되었다. 연구와 관련하여 자문과 면담을 통해 유용한 정보를 제공해 준 국내외 전문가들께 감사드린다.

References

  1. The association of korean medicine. The white papers of raw herbal medicine coverage in the national health insurance [Cheobyak geongangboheom geubyeohwa baekseo]. 2021.2.
  2. Medical today. The traction of herbal medicine coverage ①; Ministry of health and welfare showed will [Cheobyakgeubyeohwa geummulsal ①; Chujin uiji deureonaen bokjibu]. 2018.2.22. Available at: http://www.mdtoday.co.kr/mdtoday/index.html?no=312610 (Accessed 2019. 6. 24).
  3. Lim B, Jang BH, Go HY, Kim D. Yi J, Park J et al. A study on the strategy and plan for insuring the raw herbal medicines in national health insurance [Cheobyak geongangboheom bojangseong ganghwareul wihan giban guchuk yeongu]. Pusan National University. 2018.
  4. Choi B, Jo Y, Son C. Study on the State of Kampo Medical Services in Japan [Ilbonui hanbang uiryoseobiseu hyeonhwang josayeongu]. The journal of internal korean medicine. 2014;35(3):309-16.
  5. Seong H, Shin HK, Kim SJ, Kampo medical services in Japan [Ilbonui hanuihak uiryo hyeonhwang]. Korea Institute of Oriental Medicine. 1997.
  6. Jang BH, Ko SG, Lee E, Go HY, A study on the development of herbal medicine industry through related system survey [Guknae.oe hanyakjeje jedo josareul tonghan gwanryeon saneop hwalseonghwa bangan dochul]. Kyung hee university. 2015.
  7. Otsuka K. Medical dictionary of kampo practice 6th edition [漢方診療医典, 第六改正]. Nanzando [南山堂]. 2001.
  8. Machi S. Interviewed by: EunHye H. 2018.8.29.
  9. Japan kampo medicine manufacturers association. Recommended terminology for kampo products, conventional crude drug products and crude drugs [漢方.生薬英語表記]. 2019. Available at: https://www.nikkankyo.org/seihin/seihin4.htm (Accessed 2019. 6. 24).
  10. Ministry of Health, Labor and Welfare. Dispensing fee, ch-2 [調剤報酬について, 診-2]. 2009.
  11. Ministry of Health, Labor and Welfare. Guidance for approval of manufacture and sale of crude drug extracts, 1225-6 [生薬のエキス製剤の製造販売承認申請に係るガイダンス , 1225-6]. 2015.
  12. Ministry of Health, Labor and Welfare. Understanding of insurance dispensing [保険調剤の理解のために]. 2018.
  13. Kenji W. Tetsuhiro Y. Ito M. Interviewed by: EunHye H. 2018.8.28.
  14. Pharmaceuticals and medical devices agency. Standards for crude drugs and kampo preparations in Japan [日本における生薬.漢方製剤基準の策定]. 2018.
  15. Ministry of Health, Labor and Welfare. List of drug prices and information on generic drugs [薬価基準収載品目リスト及び後発医薬品に関する情報について]. 2019.
  16. Ministry of Health, Labor and Welfare. Standards for manufacturing and quality control of crude drugs [生薬及び生薬製の製造管理及び品質管理に関する基準について]. 2012.
  17. Pharmaceuticals and medical devices agency. Drug information [医療用医薬品 情報検索]. 2019. Available at: http://www.pmda.go.jp/PmdaSearch/iyakuSearch (Accessed 2019.6.24.).
  18. Ichiro A. Interviewed by: EunHye H. 2018.8.29.
  19. Kiichiro T. Interviewed by: EunHye H. 2018.8.27.
  20. Akiba T. History of kampo extracts for medical use [医療用漢方製剤の歴史]. Kampo medicine. 2010;61(7):881-88. https://doi.org/10.3937/kampomed.61.881
  21. Lee HJ. Change and status of kampo medicine [Ilbon hanyakjejeui byeoncheon mit hyeonhwang]. NIKOM report of Korean medicine policy. 2016;1(2):18-27.
  22. Ministry of Health, Labor and Welfare. Handling of complex medications, no. 804 [医療用配合剤の取扱いについて, 第804号]. 1980.
  23. Ichiro A. History of japanese kampo medicines manufacturers [日本の漢方製剤産業の歴]. 歴史学雑誌. 2015;50(1):1-6.
  24. Ministry of Health, Labor and Welfare. Handling of complex herbal medications [医療用漢方エキス制裁の取扱いについて]. 1985.
  25. Asahi. Ten deaths from side effects of herbal medicine [漢方薬 副作用で 死者10人]. 1996.3.2. Available at: http://www.sod-jp.com/page1/sikkanbetu/05/5-8.htm. (Accessed 2019.4.29.).
  26. Aoyama I, Koyama S, Hibino H. Self-medication behaviors among Japanese consumers: sex, age, and SES differences and caregivers' attitudes toward their children's health management. Asia Pacific Family Medicine, 2012;11(1):7. https://doi.org/10.1186/1447-056X-11-7
  27. Nomura K, Kitagawa Y, Yuda Y, Takano-Ohmuro H. Medicine reclassification procsses and regulations for proper use of over-the-counter self-care medicines in Japan. Risk Management and Healthcare Policy. 2016;9:172-3.
  28. Act on securing quality, efficacy and safety of products including pharmaceuticals and medical devices [医薬品, 医療機器等の品質, 有効性及び安全性の確保等に関する法律, 第108号第36条]. 2016. Available at: https://www.e-gov.go.jp (Accessed 2019.4.7.).
  29. Ministry of Health, Labor and Welfare. Central social insurance medical council [中央社会保険医療協議会]. 2019. Available at: https://www.mhlw.go.jp/stf/shingi/shingi-chuo_128154.html (Accessed 2019.4.29.).
  30. Cheong HJ, Song M, Lee SW. A comparative study on health insurance system of south korea and japan: revolve around out-ofpocket payments [Hangukgwa ilbon uiryoboheomjedo bigyo yeongu: boninbudamryuleul jungsimeuro]. The Japanese Modern Association of Korea. 2011;31:209-32.
  31. Min IS, Hahm MI, Kim SJ, Park SH. Effects and improvement of the disclosure of the noncovered services fee [Bigeubyeo jillyobiyong gonggae hyogwabunseok mit jedo gaeseon bangan yeongu]. Soonchunhyang University. 2018.
  32. Ministry of Health, Labor and Welfare. Health Insurance Act, No.70, Article 36,76,82 [健康保険法, 第70号, 第36,76,82条]. 2018.
  33. Akino W. Interviewed by: EunHye H. 2018.8.28.
  34. Hiyama Y. Interviewed by: EunHye H. 2018.8.27.
  35. Tetsuhiro Y. Interviewed by: EunHye H. 2018.8.28.
  36. Ahn HT. Health insurance payment compensation and listing procedure of medical materials: a comparison with France, Japan, and Germany [Geongangboheom jillyobi jibulbosanggwa chiryojaeryo deungjaejeolcha: peurangseu, ilbon, dokil jedowaui hyeonhwangbigyoreul jungsimeuro]. Master's thesis. Korea university graduate school. 2015.
  37. Nam HJ. The medical fee system of expensive medical equipment in Japan [Ilbonui goga uiryo jangbi jilryosuga chegye]. HIRA policy trend. 2013;7(10):87-95.
  38. Ministry of Health, Labor and Welfare. Criteria for drug price, No. 207-1 [藥價算定の基準について, 第207-1号]. 2018.
  39. Ryu CK. A Study for The Pharmaceutical Pricing Standard of the National Health Insurance in Japan [Ilbonui geongangboheom yakga sanjeonggijune gwanhan yeongu]. Korean journal of hospital management. 2009;14(4):52-70.
  40. Lee HJ. Kampo medicine insurance system and current status in Japan [Ilbon hanbang boheom jedo mit hyeonhwang]. NIKOM report of Korean medicine policy. 2017;2(1):55-9.
  41. Ministry of Health, Labor and Welfare. Calculation method of medical fee, No.434 [診療報酬の算定方法 第434号]. 2018.
  42. Net Olive. Available at: http://net-olive.jp. (Accessed 2019.4.7.).
  43. Honsoukaku Pharmacy [本草閣薬局]. Available at: https://www.honsoukaku.co.jp (Accessed 2019.4.7.).
  44. Heiando Pharmacy [平安堂薬局]. Available at: http://heiandoo.co.jp (Accessed 2019.4.7.).